Clinical trial · Observational
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University
NCT06524557CI-TRIAL-00079218unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore an effective noninvasive method for differential diagnosis of liver tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Tumor | Liver Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| with chronic liver disease | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- with chronic liver disease
- description
- patients with hepatitis B virus, hepatitis C virus and other chronic liver disease.
- interventionNames
- Diagnostic Test: with chronic liver disease
- label
- without chronic liver disease
- description
- patients without hepatitis B virus, hepatitis C virus and other chronic liver disease.
Primary outcomes (1)
- measure
- The differential diagnosis of liver tumors
- timeFrame
- 2018.01-2025.12
- description
- Multimodal ultrasound is of great value in the differential diagnosis of liver tumors
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: (1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis. Exclusion Criteria: (1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.
References
Publications (1)
- DERIVEDZhou H, Sang L, Sun Y, Gong X, Zhang J, Liu L, Wei J, Jiao W, Yu M. Performance of Ultrasonography-Based Fractal Parameters in Distinguishing Hepatocellular Carcinoma From Intrahepatic Cholangiocarcinoma. Ultrason Imaging. 2025 Jul;47(3-4):115-124. doi: 10.1177/01617346251330257. Epub 2025 Apr 15. PMID 40231713